Skip to main content

Canada Air Canada can refuse to ship monkeys for research, agency rules

A person walks by Air Canada planes at Toronto Pearson International Airport on Friday, April 13, 2012.

Michelle Siu/THE CANADIAN PRESS

Air Canada has been given the go-ahead to stop flying primates of the non-human variety.

The Canadian Transportation Agency ruled on Thursday that Canada's largest airline can refuse the shipping of monkeys for laboratory research purposes.

The petition to the agency was made last year "to align our policies with those of many other major international carriers and in response to widespread public concern," said Air Canada spokesman Peter Fitzpatrick. It followed a similar request from 1996 that was refused.

Story continues below advertisement

Air Canada had been urged by animal rights groups, such as People for the Ethical Treatment of Animals, to stop the shipment of monkeys since last year with a letter campaign. PETA champions the ban of all animals for live experimentation;

"I'm thrilled that the government is allowing our flagship airline to take a stand against cruel experiments on animals," said Pamela Anderson, one of the group's celebrity members, in an e-mail.

But the Public Health Agency of Canada and Queen's University complain that Air Canada's request is "unreasonable and unjustly discriminatory." They argue that the ruling will have a negative impact on public health and advances in medical research. Monkeys are used to test the safety of vaccines and are critical for rapid responses to infectious diseases such as the SARS outbreak in Toronto in 2003.

In its news release, however, the Canadian Transportation Agency said that the airline's request "constitutes a rational business decision" and is not discriminatory.

United/Continental is now the only major North American airline that continues to accept shipments of monkeys.

Report an error Editorial code of conduct
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

Cannabis pro newsletter